Holen Sie sich die Stockscreener-App
123.11
5.76%
6.70
Handel nachbörslich:
124.50
1.39
+1.13%
Schlusskurs vom Vortag:
$116.41
Offen:
$118.29
24-Stunden-Volumen:
918.41K
Relative Volume:
0.98
Marktkapitalisierung:
$3.54B
Einnahmen:
$267.23M
Nettoeinkommen (Verlust:
$-83.50M
KGV:
-39.59
EPS:
-3.11
Netto-Cashflow:
$-59.99M
1W Leistung:
+16.31%
1M Leistung:
+49.12%
6M Leistung:
+57.83%
1J Leistung:
+260.50%
1-Tages-Spanne:
$116.39
$123.22
1-Wochen-Bereich:
$102.97
$123.22
52-Wochen-Spanne:
$28.86
$123.22
Genedx Holdings Corp Stock (WGS) Company Profile
Firmenname
Genedx Holdings Corp
Sektor
Branche
Telefon
888-729-1206
Adresse
333 LUDLOW STREET, STAMFORD
Vergleichen Sie WGS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
123.11 | 3.34B | 267.23M | -83.50M | -59.99M | -3.11 |
|
TMO
Thermo Fisher Scientific Inc
|
484.79 | 180.28B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
209.14 | 147.31B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
663.92 | 52.18B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
120.29 | 33.33B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
190.23 | 31.60B | 15.50B | 1.33B | 2.16B | 7.34 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Piper Sandler | Overweight |
| 2025-05-15 | Eingeleitet | Guggenheim | Buy |
| 2025-05-09 | Hochstufung | Jefferies | Hold → Buy |
| 2024-08-28 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-07-10 | Eingeleitet | Craig Hallum | Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
Alle ansehen
Genedx Holdings Corp Aktie (WGS) Neueste Nachrichten
Rosen Law Firm Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action InvestigationWGS - Barchart.com
GeneDx Holdings stock hits 52-week high at 118.47 USD By Investing.com - Investing.com South Africa
GeneDx Holdings stock hits 52-week high at 118.47 USD - Investing.com
GENEDX INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
ROSEN, LEADING TRIAL ATTORNEYS, Encourages GeneDx Holdings Corp. Investors to Inquire About Securities Class Action InvestigationWGS - ACCESS Newswire
GeneDx at Canaccord Conference: Expanding Genomic Horizons - Investing.com
How Investors May Respond To GeneDx Holdings (WGS) Raising 2024 Revenue Guidance After Swing to Profit - simplywall.st
GeneDx Holdings Corp. (WGS) Sees Solid Earnings Growth Amid Rising Estimates - AInvest
Will GENEDX HOLDINGS (WGS) Gain on Rising Earnings Estimates? - Yahoo Finance
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are - Bluefield Daily Telegraph
WGS Investor News: If You Have Suffered Losses in GeneDx Holdings Corp. (NASDAQ: WGS), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
WGS Investor News: If You Have Suffered Losses in GeneDx - GlobeNewswire
Genedx Holdings Corp. shares rise 1.90% after-hours as Rosen Law Firm investigates potential securities claims. - AInvest
Should You Buy GeneDx Holdings Corp. (WGS) After Golden Cross? - Zacks Investment Research
Industry Analysts Just Upgraded Their GeneDx Holdings Corp. (NASDAQ:WGS) Revenue Forecasts By 11% - 富途牛牛
GeneDx Holdings' (NASDAQ:WGS) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance
GENEDX (WGS) ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire
William Blair Investment Management, LLC's Strategic Acquisition in GeneDx Holdings Corp - GuruFocus
GeneDx investigated for misleading statements and practices. - AInvest
Scott+Scott Attorneys at Law LLP Alerts Investors to Its Investigation Into GeneDx Holdings Corp. (NASDAQ: WGS) - GlobeNewswire
GeneDx Leadership to Present at 3 Premier Healthcare Conferences: Morgan Stanley, Wells Fargo, Canaccord - Stock Titan
GeneDx to Participate in Upcoming Investor Conferences - Business Wire
Piper Sandler reiterates Overweight rating on GeneDx stock, citing multiyear growth potential - Investing.com Canada
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Inborn Errors of Immunity as a New Indication - ADVFN Brasil
Genedx Holdings Corp. shares rise 1.59% intraday after Rosen Law Firm investigates potential securities claims. - AInvest
How does GeneDx Holdings Corp. generate profit in a changing economyCapitalize on market momentum for big wins - Jammu Links News
What catalysts could drive GeneDx Holdings Corp. stock higher in 2025Maximize gains with expert analysis - Jammu Links News
Published on: 2025-08-04 06:03:13 - Jammu Links News
Is GeneDx Holdings Corp. stock overvalued or undervaluedHigh-margin investment plays - Jammu Links News
Published on: 2025-08-04 04:10:50 - Jammu Links News
What are analysts’ price targets for GeneDx Holdings Corp. Equity Warrant in the next 12 monthsTremendous gains - Jammu Links News
How many analysts rate GeneDx Holdings Corp. Equity Warrant as a “Buy”Discover high-growth stocks for your portfolio - Jammu Links News
Should I hold or sell GeneDx Holdings Corp. Equity Warrant stock in 2025Achieve rapid capital gains with smart investing - Jammu Links News
How volatile is GeneDx Holdings Corp. stock compared to the marketInvest with confidence backed by data - Jammu Links News
Is GeneDx Holdings Corp. Equity Warrant stock overvalued or undervaluedBuild a diversified portfolio for risk mitigation - Jammu Links News
How strong is GeneDx Holdings Corp. company’s balance sheetGet timely market insights for better trades - Jammu Links News
What institutional investors are buying GeneDx Holdings Corp. stockFree Daily Trading Room Entry - Jammu Links News
How strong is GeneDx Holdings Corp. Equity Warrant company’s balance sheetBuild your wealth with consistent stock growth - Jammu Links News
When is GeneDx Holdings Corp. Equity Warrant stock expected to show significant growthAchieve rapid returns with smart investment plans - Jammu Links News
What analysts say about GeneDx Holdings Corp. Equity Warrant stockSignificant capital appreciation - Jammu Links News
Is it the right time to buy GeneDx Holdings Corp. Equity Warrant stockUnlock daily market insights for better trades - Jammu Links News
Published on: 2025-08-03 12:13:18 - Jammu Links News
Why is GeneDx Holdings Corp. Equity Warrant stock attracting strong analyst attentionStrong return on assets - Jammu Links News
What are GeneDx Holdings Corp. Equity Warrant company’s key revenue driversOutstanding trading profits - Jammu Links News
Finanzdaten der Genedx Holdings Corp-Aktie (WGS)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.96%
1.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):